Literature DB >> 19379020

(Part of) the case for a pragmatic approach to validity: comment on De Houwer, Teige-Mocigemba, Spruyt, and Moors (2009).

Brian A Nosek1, Anthony G Greenwald2.   

Abstract

In their review of validity of the Implicit Association Test and affective priming, J. De Houwer, S. Teige-Mocigemba, A. Spruyt, and A. Moors identified validity with establishment of "basic theoretical understanding" of the measures. It is agreed that theoretical understanding has an important role in making measures more valid and useful. Nevertheless, the authors conclude that scientific advancement will more often be well served by prioritizing pragmatic goals of establishing the predictive validity of the measures and their adequate sensitivity to individual differences. (PsycINFO Database Record (c) 2009 APA, all rights reserved).

Mesh:

Year:  2009        PMID: 19379020     DOI: 10.1037/a0015047

Source DB:  PubMed          Journal:  Psychol Bull        ISSN: 0033-2909            Impact factor:   17.737


  4 in total

1.  A Paradigm to Assess Implicit Attitudes towards God: The Positive/Negative God Associations Task.

Authors:  Steven Pirutinsky; Sean Carp; David H Rosmarin
Journal:  J Relig Health       Date:  2017-02

Review 2.  Implicit social cognition: from measures to mechanisms.

Authors:  Brian A Nosek; Carlee Beth Hawkins; Rebecca S Frazier
Journal:  Trends Cogn Sci       Date:  2011-03-02       Impact factor: 20.229

3.  Best research practices for using the Implicit Association Test.

Authors:  Anthony G Greenwald; Miguel Brendl; Huajian Cai; Dario Cvencek; John F Dovidio; Malte Friese; Adam Hahn; Eric Hehman; Wilhelm Hofmann; Sean Hughes; Ian Hussey; Christian Jordan; Teri A Kirby; Calvin K Lai; Jonas W B Lang; Kristen P Lindgren; Dominika Maison; Brian D Ostafin; James R Rae; Kate A Ratliff; Adriaan Spruyt; Reinout W Wiers
Journal:  Behav Res Methods       Date:  2021-09-13

4.  Brand discrimination: an implicit measure of the strength of mental brand representations.

Authors:  Mike Friedman; Thomas Leclercq
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.